(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHASE ONE MEDICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHASE ONE MEDICAL

ST13

US500000078979957

Class

42

Filing

78979957

Registration

3428830

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

10/02/2019

Trademark type

Word

Nice classes

42

Filing date

03/03/2006

Registration date

05/13/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/10/2018

Last transaction

11/10/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/14/2006

First use in commerce

08/14/2006

Drawing code

4

Owner type

16

Owner location

Cohasset, MA, US

Examiner

LATTUCA, FRANK J

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Phase One Medical, LLC
Phase One Medical, LLC

Representatives

Phase One Medical, LLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Product research and development; product research and development in the field of medical devices

Publications

History of USPTO decisions and trademark events.

39 publications found

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/02/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/02/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/10/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/10/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/10/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/10/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/04/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

11/04/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/13/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/29/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/29/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/29/2014

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

05/08/2014

E815

TEAS SECTION 8 & 15 RECEIVED

05/08/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

05/13/2008

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

04/08/2008

ALIE

ASSIGNED TO LIE

04/08/2008

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/28/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/05/2008

DPCC

DIVISIONAL PROCESSING COMPLETE

03/05/2008

IUAF

USE AMENDMENT FILED

02/12/2008

DRRR

DIVISIONAL REQUEST RECEIVED

02/12/2008

MAIL

PAPER RECEIVED

02/12/2008

EX1G

SOU EXTENSION 1 GRANTED

08/08/2007

EXT1

SOU EXTENSION 1 FILED

08/08/2007

EEXT

SOU TEAS EXTENSION RECEIVED

08/08/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

02/13/2007

PUBO

PUBLISHED FOR OPPOSITION

11/21/2006

NPUB

NOTICE OF PUBLICATION

11/01/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/12/2006

ALIE

ASSIGNED TO LIE

10/06/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/04/2006

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/28/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/27/2006

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/27/2006

GNRT

NON-FINAL ACTION E-MAILED

08/23/2006

CNRT

NON-FINAL ACTION WRITTEN

08/23/2006

DOCK

ASSIGNED TO EXAMINER

08/22/2006

NWAP

NEW APPLICATION ENTERED

03/09/2006

Continuous trademark protection

Get notified about every new filing that threatens PHASE ONE MEDICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.